COA At-a-Glance
Evidence of cognitive interviewing of draft instrument in target patient population
Evidence of internal consistency
Evidence of test-retest or inter-rater reliability
Evidence of concurrent validity
Evidence of known-groups validity
Evidence of ability to detect change over time
Evidence of responder thresholds
Inclusion of the COA in product labelling
- Overview
- Content Validity
- Reliability
- Validity
- Ability to Detect Change
- Responder Thresholds
- Reference(s) of development / validation
- Other references
- Inclusion of the COA in product labelling
- Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
- Existence of Scoring / Interpretation / User Manual
- Original language and translations
- References of translations
- Authors and contact information
- Condition of use: copyright
- Website
- Review copy
Overview
Instrument Name: Obstructive Sleep Apnea-5
Abbreviation: OSA-5
Points for Consideration:
None
Description of Tool:
The Obstructive Sleep Apnea-5 (OSA-5) is a 5-item ObsRO developed to screen and triage children at risk of obstructive sleep apnea among large numbers of referrals for sleep-disordered breathing. Parents are asked to rate their child's symptoms over the past four weeks. Items are rated on a 4-level scale ranging from 1="None of the time", 2="Some of the time", 3="Most of the time", to 4="All of the time". A higher score represents more likelihood of having obstructive sleep apnea.
Other Related Tools (if applicable):
The OSA-20 consists of 20 items to determine the impact of OSA on children's health-related quality of life. This version includes two additional items: Item 12 (Social problems) and Item 16 (School problems).
The OSA-18 consists of 18 items to determine the impact of OSA on children's health-related quality of life. This revised version does not include Item 12 (Social problems) and Item 16 (School problems) included in the OSA-20.
Minimum Qualification Required by COA Administrator: No degree requirement
Comment:
The OSA-5 was developed as an abbreviated form of the OSA-18 originally developed by Franco et al., 2000. The items included in the OSA-5 were selected based on the strongest associations with OSA found in the authors' previous work (Walter et al., 2016) and clinical experience. The OSA-5 consists of the OSA-18 Item 1 (Loud snoring), Item 2 (Breath holding spells or pauses in breathing at night), Item 3 (Choking or gasping sounds while asleep), Item 5 (Mouth breathing because of nasal obstruction) and Item 16 (Breathing problems during sleep that made you worried that they were not getting enough air). Further, the modified response scale includes four options, reduced from the original 7 options included in the OSA-18: 1="None of the time", 2="Some of the time", 3="Most of the time", and 4="All of the time".
Year: 2018
Objective of Development:
To help screen and triage children at risk of obstructive sleep apnea among large numbers of referrals for sleep-disordered breathing.
Population of Development: Age range (therapeutic indication):
Age range: 2-17 years (Children who had either polysomnography or oximetry for suspected sleep apnea)
Pediatric Population(s) in which COA has been used:
None identified
COA type: ObsRO
Number of Items 5
Mode of Administration: Caregiver-rated
Data Collection Mode: Paper and pen administration
Time for Completion: No information
Response Scales: 4-point scale: ranging from 1="None of the time", 2="Some of the time", 3="Most of the time", and 4="All of the time"
Summary of Scoring:
Available scores: A total score is obtained by summing the scores of all 5 items. The total score can range from 0 to 15.
Weighting: No
Score interpretation: Higher scores=More likelihood of having OSA.
Content Validity
Evidence of Literature Review: None identified
Evidence of Instrument Review: None identified
Evidence of Clinical or Expert Input: Yes
Evidence of concept elicitation in target patient population: Yes
Evidence of a Saturation Grid: None identified
Evidence for Selection of Data Collection Method: None identified
Recall/Observation Period: Past 4 weeks
Evidence for Selection of Reponse Options: Yes
Evidence of cognitive interviewing of draft instrument in target patient population: None identified
Evidence of Preliminary Scoring of Items and Domains: None identified
Evidence related to respondent and administrator burden: None identified
Evidence of a Conceptual Framework: None identified
Evidence of an item-tracking matrix: None identified
Evidence related to item selection: Yes
Evidence of re-testing the final version: Yes
Reliability
Internal consistency (Cronbach's alpha): Yes
Evidence of internal consistency: Soh HJ (2018) - Method: Cronbach's alpha - Results: 0.80 - Population/Disease: Children aged 2-18 years who had either polysomnography or oximetry; n=366
Test-retest Reliability (ICC):
None identified
Inter-rater/ inter-interviewer reliability (kappa):
None identified
Evidence of test-retest or inter-rater reliability: None identified
Validity
Concurrent validity (convergent, divergent):
None identified
Known-group validity:
None identified
Evidence of Translatability Assessment: None identified
Evidence related to missing data: None identified
Evidence for Selection of Recall Period: None identified
Evidence of Administration Instructions and Training Provided: None identified
Evidence of concurrent validity: None identified
Evidence of known-groups validity: None identified
Evidence of ability to detect change over time: None identified
Ability to Detect Change
Ability to detect change (Responsiveness):
None identified
Responder Thresholds
Responder Thresholds:
None identified
Evidence of responder thresholds: None identified
Reference(s) of development / validation
Soh HJ, Rowe K, Davey MJ, Horne RSC, Nixon GM. The OSA-5: Development and validation of a brief questionnaire screening tool for obstructive sleep apnea in children. Int J Pediatr Otorhinolaryngol. 2018 Oct;113:62-66. doi: 10.1016/j.ijporl.2018.07.029. Epub 2018 Jul 19. PMID: 30174012. Full Text Article: https://pubmed.ncbi.nlm.nih.gov/30174012/
Other references
Franco RA Jr, Rosenfeld RM, Rao M. First place--resident clinical science award 1999. Quality of life for children with obstructive sleep apnea. Otolaryngol Head Neck Surg. 2000 Jul;123(1 Pt 1):9-16. doi: 10.1067/mhn.2000.105254. PMID: 10889473. Full Text Article: https://pubmed.ncbi.nlm.nih.gov/10889473/
Walter, L. M., Biggs, S. N., Cikor, N., Rowe, K., Davey, M. J., Horne, R. S., & Nixon, G. M. (2016). The efficacy of the OSA-18 as a waiting list triage tool for OSA in children. Sleep and Breathing, 20, 837-844. Full Text Article: https://pubmed.ncbi.nlm.nih.gov/26669876/
Inclusion of the COA in product labelling
None identified
Inclusion of the COA in product labelling (agency, drug, drug approval date, COA results) from PROLABELS search
None identified
Existence of Scoring / Interpretation / User Manual
Yes
Original language and translations
None identified
References of translations
None identified
Condition of use: copyright
None identified
Website
None identified
Review copy
https://www.sciencedirect.com/science/article/abs/pii/S0165587618303446#:~:text=In%20conclusion%2C%20we%20have%20developed,symptoms%20of%20sleep%20disordered%20breathing